Biosimilar Use in Breast Cancer Treatment: A National Survey of Brazilian Oncologists' Opinions, Practices, and Concerns.

Heloisa Magda ResendeLeandro LadislauAna Carolina F CardosoJuliana Dinéia P BrandãoBiazi R AssisPaola CardosoPedro Henrique A MarassiVivienne Castilho

Published in: JCO global oncology (2021)

Oncologists demonstrated a high level of knowledge of biosimilars and encouraging levels of prescriber use; however, extrapolation and switching treatment regimens are barriers to the effective use of biosimilars in cancer treatment. Efforts should be concentrated on strategies involving medical education programs on biosimilars.

Keyphrases

healthcare
medical education
primary care
public health
combination therapy
young adults
palliative care